STOCK TITAN

Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2025 MedTech Innovation Spotlight

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Inspire Medical Systems (NYSE: INSP), a medical technology company specializing in minimally invasive solutions for obstructive sleep apnea, announced its participation in the Wells Fargo 2025 MedTech Innovation Spotlight. The company's management team will present on June 13, 2025, at 12:00 p.m. Eastern Time. The presentation will be available through a live webcast, with a replay accessible for two weeks afterward in the Event Archive section of Inspire's Investor website.
Inspire Medical Systems (NYSE: INSP), un'azienda di tecnologia medica specializzata in soluzioni minimamente invasive per l'apnea ostruttiva del sonno, ha annunciato la sua partecipazione al Wells Fargo 2025 MedTech Innovation Spotlight. Il team di gestione dell'azienda presenterà il 13 giugno 2025 alle 12:00 ora della costa orientale. La presentazione sarà disponibile tramite una diretta webcast, con una replica accessibile per due settimane successive nella sezione Event Archive del sito web per gli investitori di Inspire.
Inspire Medical Systems (NYSE: INSP), una empresa de tecnología médica especializada en soluciones mínimamente invasivas para la apnea obstructiva del sueño, anunció su participación en el Wells Fargo 2025 MedTech Innovation Spotlight. El equipo directivo de la compañía realizará una presentación el 13 de junio de 2025 a las 12:00 p.m., hora del Este. La presentación estará disponible a través de una transmisión en vivo por internet, con una repetición accesible durante dos semanas posteriores en la sección Event Archive del sitio web para inversores de Inspire.
Inspire Medical Systems(NYSE: INSP)는 폐쇄성 수면 무호흡증에 대한 최소 침습 솔루션을 전문으로 하는 의료 기술 회사로서 Wells Fargo 2025 MedTech Innovation Spotlight에 참여한다고 발표했습니다. 회사 경영진은 2025년 6월 13일 동부 표준시 기준 오후 12시에 발표를 진행할 예정입니다. 발표는 라이브 웹캐스트를 통해 제공되며, Inspire 투자자 웹사이트의 이벤트 아카이브 섹션에서 이후 2주간 다시보기로 이용할 수 있습니다.
Inspire Medical Systems (NYSE : INSP), une entreprise de technologie médicale spécialisée dans les solutions peu invasives pour l'apnée obstructive du sommeil, a annoncé sa participation au Wells Fargo 2025 MedTech Innovation Spotlight. L'équipe de direction de l'entreprise présentera le 13 juin 2025 à 12h00, heure de l'Est. La présentation sera disponible via un webcast en direct, avec une rediffusion accessible pendant deux semaines dans la section Event Archive du site web des investisseurs d'Inspire.
Inspire Medical Systems (NYSE: INSP), ein Medizintechnikunternehmen, das sich auf minimalinvasive Lösungen für obstruktive Schlafapnoe spezialisiert hat, gab seine Teilnahme am Wells Fargo 2025 MedTech Innovation Spotlight bekannt. Das Managementteam des Unternehmens wird am 13. Juni 2025 um 12:00 Uhr Eastern Time präsentieren. Die Präsentation wird über einen Live-Webcast verfügbar sein, mit einer Wiederholung, die für zwei Wochen danach im Event-Archiv-Bereich der Investorenseite von Inspire zugänglich ist.
Positive
  • None.
Negative
  • None.

MINNEAPOLIS, May 30, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will participate in the Wells Fargo 2025 MedTech Innovation Spotlight on Friday, June 13, 2025.

Inspire is scheduled to present at 12:00 p.m. Eastern Time. The presentation will be accessible via a live webcast here.

A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443


FAQ

When is Inspire Medical Systems (INSP) presenting at the Wells Fargo MedTech Innovation Spotlight 2025?

Inspire Medical Systems will present on Friday, June 13, 2025, at 12:00 p.m. Eastern Time.

How can investors access Inspire Medical Systems' (INSP) Wells Fargo presentation?

The presentation will be accessible via live webcast, with a replay available for two weeks in the Event Archive section of Inspire's Investor website at investors.inspiresleep.com.

What is Inspire Medical Systems' (INSP) main business focus?

Inspire Medical Systems focuses on developing and commercializing innovative, minimally invasive solutions for patients with obstructive sleep apnea.

How long will the replay of Inspire Medical Systems' (INSP) Wells Fargo presentation be available?

The webcast replay will be available for two weeks following the presentation in the Event Archive section of Inspire's Investor website.
Inspire Medical

NYSE:INSP

INSP Rankings

INSP Latest News

INSP Stock Data

4.30B
27.84M
2.15%
115.59%
10.58%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
GOLDEN VALLEY